NCT06824129View on ClinicalTrials.gov

Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR

Not yet recruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

June 30, 2026

Conditions
Complicated Urinary Tract Infection
All Listed Sponsors
lead

QIAGEN Gaithersburg, Inc

INDUSTRY

NCT06824129 - Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR | Biotech Hunter | Biotech Hunter